Russia’s “Sputnik-V” COVID-19 vaccine created an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that was praised by Moscow as an answer to its critics.
The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants producing antibodies to the new coronavirus and no severe side effects, The Lancet said.
“The two 42-day trials – including 38 healthy adults each – did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.
“Large, long-term trials including a placebo comparison and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.
United States State Department spokesperson Matthew Miller said on Wednesday that no humanitarian aid entered…
United States President Joe Biden told CNN’s Erin Burnett in an exclusive interview on Wednesday…
President of the Republic, Kais Saied, welcomed this Wednesday morning, at Carthage Palace, the Minister…
The interim delegate of Foussana, Jawhar Chaabani, confirmed in a statement to the press, today Wednesday,…
The prosecution at the court of first instance of Tunis authorized, on Wednesday, agents of…
The General Directorate of the National Guard reported today, Wednesday, in a press release, that…
This website uses cookies.